| Dr Joshua David Justice, DO | |
|
6400 Dutchmans Pkwy, Suite 125, Louisville, KY 40205-3351 | |
| (502) 896-8700 | |
| (502) 896-0813 |
| Full Name | Dr Joshua David Justice |
|---|---|
| Gender | Male |
| Speciality | Ophthalmology |
| Experience | 17 Years |
| Location | 6400 Dutchmans Pkwy, Louisville, Kentucky |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1710185277 | NPI | - | NPPES |
| 7100188720 | Medicaid | KY |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207W00000X | Ophthalmology | 03386 (Kentucky) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Jewish Hospital - Shelbyville | Shelbyville, KY | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Kentucky Eye Care Psc | 5092798389 | 11 |
News Archive
Groundbreaking work by a team of UK scientists has identified, for the first time, a link between changes in the DNA of newborn babies, folic acid supplementation during pregnancy, and birth weight.
There's a new treatment option available for patients with AL amyloidosis: daratumumab. Studied in a prospective clinical trial, only one of the two clinical trials of this agent in AL amyloidosis worldwide, researchers have found this anti-cancer drug to be well tolerated and effective in patients with relapsed AL amyloidosis when used with appropriate pre- and post-infusion medications.
Sanofi and Regeneron Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration (FDA) has granted Priority Review of the Biologics License Application (BLA) for the investigational agent ZALTRAP (aflibercept) concentrate for solution for infusion in combination with the irinotecan-fluoropyrimidine-based chemotherapy in patients with metastatic colorectal cancer (mCRC) previously treated with an oxaliplatin-containing regimen.
The first large-scale population-based study on the association between the SARS-CoV-2 vaccines and Bell's palsy confirms that the beneficial and protective effects of the vaccines far outweigh the risk of this rare adverse event.
Americans for Prosperity, the Tea Party group that has made rolling back the health care law one of its priorities, is starting a $2 million campaign of television, radio and Internet advertisements aimed at lawmakers facing tough re-election battles in four House swing districts (Stolberg, 10/23).
› Verified 6 days ago
| Entity Name | Kentucky Eye Care Psc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1588748784 PECOS PAC ID: 5092798389 Enrollment ID: O20040608001361 |
News Archive
Groundbreaking work by a team of UK scientists has identified, for the first time, a link between changes in the DNA of newborn babies, folic acid supplementation during pregnancy, and birth weight.
There's a new treatment option available for patients with AL amyloidosis: daratumumab. Studied in a prospective clinical trial, only one of the two clinical trials of this agent in AL amyloidosis worldwide, researchers have found this anti-cancer drug to be well tolerated and effective in patients with relapsed AL amyloidosis when used with appropriate pre- and post-infusion medications.
Sanofi and Regeneron Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration (FDA) has granted Priority Review of the Biologics License Application (BLA) for the investigational agent ZALTRAP (aflibercept) concentrate for solution for infusion in combination with the irinotecan-fluoropyrimidine-based chemotherapy in patients with metastatic colorectal cancer (mCRC) previously treated with an oxaliplatin-containing regimen.
The first large-scale population-based study on the association between the SARS-CoV-2 vaccines and Bell's palsy confirms that the beneficial and protective effects of the vaccines far outweigh the risk of this rare adverse event.
Americans for Prosperity, the Tea Party group that has made rolling back the health care law one of its priorities, is starting a $2 million campaign of television, radio and Internet advertisements aimed at lawmakers facing tough re-election battles in four House swing districts (Stolberg, 10/23).
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Joshua David Justice, DO 6400 Dutchmans Pkwy, Suite 125, Louisville, KY 40205-3351 Ph: (502) 896-8700 | Dr Joshua David Justice, DO 6400 Dutchmans Pkwy, Suite 125, Louisville, KY 40205-3351 Ph: (502) 896-8700 |
News Archive
Groundbreaking work by a team of UK scientists has identified, for the first time, a link between changes in the DNA of newborn babies, folic acid supplementation during pregnancy, and birth weight.
There's a new treatment option available for patients with AL amyloidosis: daratumumab. Studied in a prospective clinical trial, only one of the two clinical trials of this agent in AL amyloidosis worldwide, researchers have found this anti-cancer drug to be well tolerated and effective in patients with relapsed AL amyloidosis when used with appropriate pre- and post-infusion medications.
Sanofi and Regeneron Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration (FDA) has granted Priority Review of the Biologics License Application (BLA) for the investigational agent ZALTRAP (aflibercept) concentrate for solution for infusion in combination with the irinotecan-fluoropyrimidine-based chemotherapy in patients with metastatic colorectal cancer (mCRC) previously treated with an oxaliplatin-containing regimen.
The first large-scale population-based study on the association between the SARS-CoV-2 vaccines and Bell's palsy confirms that the beneficial and protective effects of the vaccines far outweigh the risk of this rare adverse event.
Americans for Prosperity, the Tea Party group that has made rolling back the health care law one of its priorities, is starting a $2 million campaign of television, radio and Internet advertisements aimed at lawmakers facing tough re-election battles in four House swing districts (Stolberg, 10/23).
› Verified 6 days ago
Dr. Brennan P Greene, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 1536 Story Ave, The Eye Care Institute Building, Louisville, KY 40206 Phone: 502-589-1500 Fax: 502-589-1556 | |
Theodore M Wandzilak, MD Ophthalmology Medicare: Medicare Enrolled Practice Location: 1348 Poplar Level Rd, Louisville, KY 40217 Phone: 502-634-8100 Fax: 502-637-6396 | |
Donald Walter Bennett, OD MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 1935 Bluegrass Ave, Suite 200, Louisville, KY 40215 Phone: 502-895-0040 Fax: 502-361-4488 | |
Dr. Mark Cassol, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 800 Zorn Ave, Louisville, KY 40206 Phone: 502-287-4000 | |
Lawrence Tenkman, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 1935 Bluegrass Ave, Suite 200, Louisville, KY 40215 Phone: 502-895-0040 Fax: 502-361-4488 | |
Dr. Jacob Jones Yunker, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 3810 Springhurst Blvd, Suite 100, Louisville, KY 40241 Phone: 502-897-9881 Fax: 502-897-9824 | |
Christopher J Compton, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 301 E Muhammad Ali Blvd, Louisville, KY 40202 Phone: 502-852-1665 |